EUVIMEDEUVIMED entdecken
Crossref

Immunotherapy advances in head and neck cancer care: implications for prescribers

Aysha Mendes

Journal of Prescribing Practice · 02.04.2026 · 8 (4) · 144-147

DOI: 10.12968/jprp.2026.0040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Prescribing Practice, erschienen am 02.04.2026. Verfasst von Aysha Mendes. Die Arbeit nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aysha Mendes discusses how pembrolizumab is reshaping the treatment of locally advanced head and neck cancer by introducing immunotherapy into treatment and care, requiring prescribers to recognise and support co-ordinated, patient-centred management across settings

Zitieren

APA

Mendes, A. (2026). Immunotherapy advances in head and neck cancer care: implications for prescribers. Journal of Prescribing Practice, 8(4), 144-147. https://doi.org/10.12968/jprp.2026.0040

Vancouver

Mendes A. Immunotherapy advances in head and neck cancer care: implications for prescribers. Journal of Prescribing Practice. 2026;8(4):144-147. doi:10.12968/jprp.2026.0040

BibTeX
@article{Mendes2026,
  author = {Mendes, Aysha},
  title = {Immunotherapy advances in head and neck cancer care: implications for prescribers},
  journal = {Journal of Prescribing Practice},
  year = {2026},
  volume = {8},
  number = {4},
  pages = {144--147},
  doi = {10.12968/jprp.2026.0040}
}
Kostenlos starten →